Skip to main content
Download PDF

Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy

Journal of Nanobiotechnology volume 21, Article number: 438 (2023) Cite this article

The Original Article was published on 26 September 2023

Correction: Journal of Nanobiotechnology (2023) 21:347

https://doi.org/10.1186/s12951-023-02106-8

Following publication of the original article [1], the figure legends in additional file were mistakenly marked in blue text. The correct version of ESM has been included in this correction and the original article [1] has been corrected.

Reference

  1. Shi C, Jian C, Wang L, et al. Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy. J Nanobiotechnol. 2023;21(1):347.

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Chen Shi, Chen Jian, Lulu Wang, Chen Gao, Zhiwen Fu & Tingting Wu

  2. Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, 430022, China

    Chen Shi, Zhiwen Fu & Tingting Wu

  3. Affiliated Hospital of Yunnan University, Kunming, 650000, China

    Ting Yang

Authors
  1. Chen Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chen Jian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lulu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chen Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ting Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhiwen Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tingting Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tingting Wu.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s12951-023-02106-8.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shi, C., Jian, C., Wang, L. et al. Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy. J Nanobiotechnol 21, 438 (2023). https://doi.org/10.1186/s12951-023-02140-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12951-023-02140-6

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us